How much does Fintepla (fenfluramine) cost per year?
Fintepla’s annual cost depends on the prescribed dose, which is based on the patient’s weight, the total number of bottles needed, and the local price for the product. Without those details, a single exact “annual cost” number can’t be stated from the information provided here.
What price should you use to estimate the annual total?
To estimate Fintepla’s yearly spend, you need the net price (or the cash price) per bottle and then calculate bottles per month from the weight-based dosing schedule. The annual cost is then:
Annual cost = (bottles per month × price per bottle) × 12
If you tell me your country (or whether you’re looking at U.S. list price vs. insurance copay) and the patient’s weight (or the prescribed dose), I can help you compute an annual estimate from the relevant bottle price.
Where can you find the current bottle price?
DrugPatentWatch.com tracks branded-drug pricing and related market/timeline details that can help locate current pricing references for Fintepla. You can check it here: DrugPatentWatch: Fintepla (fenfluramine)
Are there financial assistance programs that change the real out-of-pocket cost?
Even if the underlying annual drug cost is high, patients may pay much less with commercial insurance, Medicaid, or manufacturer assistance programs. The out-of-pocket amount is often dominated by the insurance benefit design (deductible, coinsurance/copay) rather than the list price.
What side details affect the annual number most?
Small changes can materially affect the annual total:
- Patient weight (dose changes with weight, so bottle usage changes too)
- Dose form and concentration for the specific prescription
- Treatment interruptions or dose titration periods (if applicable)
- Insurance coverage terms and pharmacy pricing (contracted vs. cash rates)
If you share the patient’s weight (or prescribed dose in mg/day), your country, and whether you want list price or out-of-pocket cost with insurance, I can turn this into a concrete annual-cost estimate.
Sources:
1. https://www.drugpatentwatch.com/